Analyzing the Mechanistic Basis of Ritlecitinib's Therapeutic Effects in Alopecia Areata

    November 2025 in “ Journal of Investigative Dermatology ”
    Arnaud Lejeune, J. Viola-Söhnlein, Thomas Rouillé … Marta Bertolini
    Studysummary Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jidonline.org →
    Discuss this study in the Community →